Background Aboriginal Australians experience a higher risk of diabetes than the general Australian population. In this paper, we conducted a nested case-control study to determine whether the presence of microalbuminuria and macroalbuminuria is associated with the development of diabetes among diabetes-free Aboriginal people at baseline.
However, current physical inactivity and obesity may not fully explain the high risk of type 2 diabetes in Aboriginal people. There has been considerable focus on the concept of microalbuminuria, not only because it predicts renal disease in diabetes but also because it relates to premature mortality in the diabetic and in the general population. Albuminuria in Aboriginal people is a major risk factor for renal disease 3 and cardiovascular disease. 4 Albuminuria can also be present at the time of diagnosis of diabetes. An increased prevalence of microalbuminuria has been observed among those with impaired fasting glucose before developing clinically diagnosed diabetes. 5 Mykkanen et al. 6 reported microalbuminuria predicted the development of diabetes independently of blood pressure level. Brantsman et al. 7 hypothesized that the presence of increased urine albumin excretion in the non-diabetic population is associated with an increased risk of development of type 2 diabetes. Their 4 year follow-up data suggest that
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urinary albumin excretion is an independent predictor of diabetes. 7 However, their data were mainly from a Caucasian population in The Netherlands. Their findings need to be confirmed in other populations. Confounding is a major concern in most observational studies. People with diabetes have significantly higher levels of most risk factors such as body mass index (BMI), waist circumference, glucose, and lipids than those without diabetes. In this study, we examine the association between albuminuria and type 2 diabetes in an Aboriginal population using an individually matched nested case-control study design.
Subjects, materials, and methods
In 1992 a community-wide renal disease screening programme was started in a remote Northern Territory Aboriginal community in Australia. Participants were offered a baseline examination and testing between 1992 and 1995. Eight hundred and eight two (882) adults aged 20-74 years were followed until April 30, 2005 . During the baseline visit, a fasting venous blood sample was drawn for plasma glucose, and serum total cholesterol and triglycerides measurements. For those free from diabetes at baseline, plasma glucose levels were also measured 2 h after a 75 g oral glucose challenge. An individual with a 2 h plasma glucose level of 7.8-11.0 mmol/l was considered as having impaired glucose tolerance (IGT).
Urinary albumin concentration was measured by the Beckman immunoassay. A urine albumin to creatinine ratio (ACR) was calculated (mg/mmol). Previous studies in Aboriginal people used 3.4 and 34 mg/mmol as cut-off for microalbuminuria and macro (or overt) albuminuria. [8] [9] [10] However, to be consistent with recent studies, this study defined normoalbuminuria as a urine ACR ,2.5 mg/mmol, microalbuminuria as a urine ACR 2.5-25 mg/mmol, and macroalbuminuria as a urine ACR .25 mg/mmol. [11] [12] [13] In addition, baseline urine ACR values were categorized into tertiles based on the sex-specific distribution of the total study population. High sensitivity C-reactive protein concentrations were measured using the immunoturbidimetric C-reactive protein assay on a Hitachi 917 analyser (Roche Diagnostics Australia) with a detection limit of 0.03 mg/l. The assay's analytical range was from 0.1 to 20 mg/l. Samples with values .20 mg/l were measured using dilution techniques. The imprecision of the assay is ,5%. Other risk factors were measured, such as blood pressures, serum cholesterol, triglycerides, BMI, cigarette smoking, alcohol drinking, and the presence of diabetes, and have been described elsewhere. [14] [15] [16] A total of 132 participants who either had known diabetes before the baseline examination or were newly diagnosed as having diabetes at the baseline examination according to the World Health Organisation (WHO) 1999 criteria 17 
Statistical analysis
We used a matched t-test to assess differences in means and the McNemar test to assess for differences in proportions. Since the urine ACR, plasma glucose, and C-reactive protein values were skewed, the logarithmic transformed values were used and their geometric means were presented. Conditional logistic regression was used to examine the association between diabetes and urine ACR values. Crude and adjusted odds ratios and their 95% confidence intervals (95% CIs) were calculated with the lowest urine ACR group as reference. Since each case was matched by a control with the same sex, sex cannot be a possible confounder. However, the potential residual confounding effects of age and BMI were further assessed in the multiple conditional logistic regressions along with other non-matched variables such as serum cholesterol, C-reactive protein, fasting plasma glucose, and impaired plasma glucose status. Interactions between ACR and other variables were tested. We also used a logarithmic transformation of ACR as a continuous variable to assess its association with diabetes and its interactions with other factors as conducted in one of previous studies. 7 All analyses were performed using Stata 9.0. 18 
Results
Baseline characteristics of study participants who were subsequently diagnosed with diabetes (cases) and those remaining free from diabetes (controls) are shown in Table 1 . Since sex, age, and BMI are matching variables, as expected for successful matching, cases and controls are similar in those variables. Cases had higher serum cholesterol, plasma glucose, and C-reactive protein levels, and a higher proportion of participants with IGT than controls. There were no statistically significant differences in blood pressures, triglycerides, smoking and drinking, and waist circumferences. The geometric means of urine ACR was significantly higher among cases than among controls. Table 2 shows higher proportions of microalbuminuria, macroalbuminuria, and participants in higher tertile groups among cases than among controls.
In age, sex, and BMI matched analysis, the odds ratios of incident diabetes were 2.22 (95% CI 1.11-4.48) and 3.32 (95% CI 1.61-6.85) for middle and upper tertiles, respectively, with the lower tertile group as reference. Similarly, odds ratios for microalbuminuria and macroalbuminuria were 2.22 (95% CI 1.15-4.29) and 2.69 (95% CI 1.30-5.56), respectively, relative to the normal albuminuria group. Interactions between albuminuria and other variables were examined and no significant interaction terms were observed. Adjusting for age and BMI had little impact on the effect estimate, as both were matching variables. Even after adjusting for possible confounding factors collected in this study, the associations between diabetes and elevated levels of ACR remained statistically significant. The adjusted odds ratios were 2.36 (95% CI 1.01-5.50) and 3.27 (95% CI 1.38-7.77) for middle and upper tertiles, and 1.90 (95% CI 0.88-4.06) and 2.51 (95% CI 1.08-5.87) for microalbuminuria and macroalbuminuria groups, respectively. Crude and adjusted odds ratios for log (ACR) as a continuous variable were significantly higher than the null effect.
Discussion
In this matched nested case-control study, we found that an elevated urine ACR value is associated with the development of diabetes in Aboriginal people. This association is independent of age, sex, BMI, serum cholesterol, C-reactive protein, and fasting plasma glucose. Our findings suggest that albuminuria can precede and predict the development of diabetes in Aboriginal people.
Albuminuria has usually been considered a consequence of diabetes. 19 It has been associated with increased cardiovascular risk in populations with and without diabetes. 13, [20] [21] [22] In
Aboriginal people, albuminuria predicts the risk of coronary heart disease independent of traditional risk factors. 4 Several studies have demonstrated that microalbuminuria occurs in individuals without diabetes. 19, 23 Only two studies have examined whether it predicts the development of diabetes among people without diabetes. 6, 7 Both studies were conducted in Caucasian populations. Diabetes cases were determined during 4.2 years of follow-up in Brantsma et al.'s study 7 and over 3.5 years in the study by
Mykkanen et al. 6 This nested case-control study is the first one in a high-risk indigenous population and has the longest follow-up of 11 years. The mechanism of the association is not clear. Confounding effects are a major concern for an observational epidemiological study. Albuminuria is associated with the insulin resistance and metabolic syndrome, 23, 24 and the presence of the metabolic syndrome and insulin resistance increases the risk of diabetes. [25] [26] [27] In this study, we did not identify individuals with metabolic syndrome, but the major risk components of metabolic syndrome were adjusted for, either through the matched study design or multiple conditional logistic regressions. After such adjustment, the association between diabetes and albuminuria remained. Albuminuria and diabetes may also share other risk factors that are not currently known. Since the onset of type 2 diabetes is generally held to be at least several years before clinical diagnosis, 28 the pathophysiology of diabetes related vascular complications probably begins before the diagnosis of diabetes. Microalbuminuria is a marker of endothelial dysfunction, which may occur with early renal disease 29 and before the current diagnosis of diabetes. Although the underlying mechanism of the association is still not clear, it is important to know that the presence of microalbuminuria and macroalbuminuria can precede diabetes and independently predict the risk of future diabetes. Improving kidney function may be potentially beneficial to preventing diabetes. Our results suggest that microalbuminuria and macroalbuminuria can at least be useful for identifying persons at increased risk of diabetes regardless of whether the association is causal.
Our findings have particular clinical and public health implications for Aboriginal Australians since a high prevalence of albuminuria has also been found in many different Aboriginal communities. 8, 10, 30 We have already reported that, in this study population, .30% of adults have microalbuminuria and 20% have macroalbuminuria. 4 Our study had several limitations. First, the diabetes events were identified through hospital records and clinical records. It is likely that some undetected cases were included in the control group. The effect is likely to be underestimated owing to this bias. Second, those with albuminuria may be more likely to visit their doctors for other health problems. Therefore, the presence of diabetes among them is more likely to be identified. If this bias is present, it will overestimate the true association between albuminuria and diabetes, although there is no evidence on this. Third, albuminuria in this study was defined using random urine ACR values rather than 24 h urine collection for urinary albumin excretion. However, it has been found that spot ACR is a good screening test for microalbuminuria. 31 Fourth, because the study participants
were Aboriginal adults from a remote community in the Northern Territory of Australia, the results may not be generalizable to other populations. The findings in the two Caucasian populations already cited, however, suggest otherwise. Branstma et al. found that the predictive value of urine albumin excretion for diabetes was modified by the level of C-reactive protein. Urinary albumin excretion predicts the development of diabetes most strongly when the level of C-reactive protein is low. 7 No significant interaction between C-reactive protein and urine ACR was observed in our study. This may be due to a relatively small sample size.
Compared with two previous studies, 6, 7 this study used a different study design and different measuring method for albuminuria in a different population. However, the findings that the presence of microalbuminuria and macroalbuminuria predicts the future development of diabetes are consistent. 
